These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 36404640)
1. Early myocardial oedema can predict subsequent cardiomyopathy in high-dose anthracycline therapy. Muehlberg F; Kornfeld M; Zange L; Ghani S; Reichardt A; Reichardt P; Schulz-Menger J ESC Heart Fail; 2023 Feb; 10(1):616-627. PubMed ID: 36404640 [TBL] [Abstract][Full Text] [Related]
2. Native myocardial T1 time can predict development of subsequent anthracycline-induced cardiomyopathy. Muehlberg F; Funk S; Zange L; von Knobelsdorff-Brenkenhoff F; Blaszczyk E; Schulz A; Ghani S; Reichardt A; Reichardt P; Schulz-Menger J ESC Heart Fail; 2018 Aug; 5(4):620-629. PubMed ID: 29673122 [TBL] [Abstract][Full Text] [Related]
3. Ultrahigh-field cardiovascular magnetic resonance T1 and T2 mapping for the assessment of anthracycline-induced cardiotoxicity in rat models: validation against histopathologic changes. J Cardiovasc Magn Reson; ; . PubMed ID: 34134713 [TBL] [Abstract][Full Text] [Related]